Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01787448 · ClinicalTrials.gov registry record · Phase 1
RIPT of Ibuprofen Topical Gel
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 234
- Enrollment target
NCT01787448: Completed Phase 1 study, sponsored by Pfizer.
NCT01787448 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 234 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (290% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01787448, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 234 participants
- Enrollment target
Study Summary
This study is being conducted to determine the potential of Ibuprofen 5% Topical Gel and its vehicle gel to cause sensitization after repeated topical application to healthy skin of human subjects under controlled conditions.
Interventions
- DRUG Topical gel vehicle
- DRUG Sodium chloride solution 0.9% (saline)
- DRUG Sodium lauryl sulfate 0.1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
What the finished NCT01787448 record still lists
NCT01787448 is an interventional study that assigns participants to a tested intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (290% higher).
The record links to 0 conditions, and to 3 interventions - of which Topical gel vehicle is the first listed.
NCT01787448 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01787448 about?
NCT01787448 is a clinical study titled "RIPT of Ibuprofen Topical Gel". This study is being conducted to determine the potential of Ibuprofen 5% Topical Gel and its vehicle gel to cause sensitization after repeated topical application to healthy skin of human subjects under controlled conditions.
What is the current status of trial NCT01787448?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 234 participants. The study started on 2013-01. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01787448?
The interventions under investigation include: Topical gel vehicle (DRUG), Sodium chloride solution 0.9% (saline) (DRUG), Sodium lauryl sulfate 0.1% (DRUG).
Who is sponsoring clinical trial NCT01787448?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01787448's enrollment target sits among peer trials
234 212th of 2000 higher than 1,787 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia